PSA Anxiety Before and After Treatment

Prostate cancer follow-up is unusual. Most cancers are watched with scans at set intervals. This one is watched with a blood test that gives a single, precise, comparable number. That precision is useful in clinic and corrosive in the mind. The number invites comparison with the last one, and the one before, down to a decimal place that may mean nothing.

The pattern that follows is well described in the prostate cancer literature. Tension builds in the days before the blood draw. It spikes while you wait for the result. Relief follows, then fades as the next test comes near. Urology and oncology clinics know it well. It is a feature of this form of surveillance, not a personal weakness. It happens to men who are doing well just as reliably as to men who are not.

NCI is direct about the limits: "a single elevated PSA measurement in someone who has a history of prostate cancer does not always mean that the cancer has come back." Clinicians read the trend across several tests, not one point.

PSA is made by normal prostate cells as well as cancer cells. NCI lists several non-cancer causes of a raised level. They include benign prostatic hyperplasia, meaning an enlarged prostate, and prostatitis, meaning an inflamed prostate. The list also covers infection, inflammation, a recent biopsy, hard exercise and ejaculation. Laboratory assays differ too. A value from a new lab may not compare directly with your history. Flag it if your testing site has changed.

After radical prostatectomy, the prostate is gone, so PSA should be undetectable. A level of 0.2 ng/mL or above defines biochemical recurrence. It is generally confirmed on repeat testing.

After radiation therapy, prostate tissue remains and still makes small amounts of PSA. So no zero is expected. The widely used standard is nadir plus 2. Nadir means the lowest level your PSA reached after treatment. The threshold is a rise of 2 ng/mL or more above it.

These are thresholds for further assessment. They are not instructions to start treatment.

What clinicians want from a rising PSA is its speed. Doubling time is the standard measure, and it is worked out from a series of readings. NCI's professional guidance on prostate cancer notes that a short doubling time after treatment has been examined as a surrogate endpoint for prostate cancer mortality. That work was a retrospective analysis of more than 8,600 patients, and the short doubling time was under three months. Long doubling times, measured in years, describe a very different situation.

The same guidance is careful about the limits of PSA kinetics. In one surveillance cohort, baseline PSA and rate of change were linked to metastasis risk. But the accuracy of separating indolent disease from progressive disease was described as poor at all the cut points examined. So doubling time informs the picture. It does not decide it.

This is the point most often missing from what men are told. NCI's professional guidance states that a substantial proportion of patients with an elevated or rising PSA after surgery stay clinically free of symptoms for extended periods. It cites a median time from biochemical recurrence to clinical metastasis of around eight years. It also says plainly that biochemical evidence alone may not be sufficient to start additional treatment.

So a rising PSA usually opens a period of assessment rather than an emergency. That means repeat testing, doubling time calculation, and sometimes imaging.

• Compress the gap. Ask for the blood draw and the results conversation to sit close together. Most of the distress lives in the days you spend holding a number you cannot read.
• Decide the rules in advance. Ask your urologist what result would prompt a call, what would prompt imaging, and what would simply be recorded. A threshold agreed in advance turns an unknown into a decision rule.
• Question ultrasensitive assays. Assays that report to two or three decimal places create movement at levels that may not change your care. Ask directly whether the extra precision is changing anything.
• Prepare the draw. Ask whether to avoid ejaculation, cycling or heavy exercise beforehand. Try to use the same laboratory each time.
• Plan the day. Many men book tests early in the week. They put something absorbing straight afterwards, rather than an empty afternoon.
• Treat severe anxiety as treatable. Broken sleep, avoided appointments and intrusive worry between tests all respond to psychological treatment. Ask for a referral. Cancer centers have people who do exactly this work.

• NCI PDQ — Prostate Cancer Treatment (Health Professional Version)
• NCI — Support for people coping with cancer
• NCCN Guidelines for Patients